Skip to main content

Real-world data in the United Kingdom: Opportunities and challenges

21Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

Real-world data is that collected outside the constraints of controlled clinical trials and is increasingly informing decision-making in healthcare. The landscape of real-world data in the United Kingdom is set to evolve over the coming months as the government plans to build on databases currently in place by collecting patient data from all family practices and linking this information with hospital records. This initiative, called care.data, has the potential to be an invaluable resource. However, the programme has been criticized on grounds of data privacy, which has led to an extended delay in its implementation and the expectation that a large number of people will opt out. Opt-outs may introduce substantial biases to the dataset, and understanding how to account for these presents a significant challenge for researchers. For the scope and quality of real-world evidence in the United Kingdom to be realised, and for this information to be used effectively, it is essential to address this challenge.

Cite

CITATION STYLE

APA

McDonald, L., Lambrelli, D., Wasiak, R., & Ramagopalan, S. V. (2016, June 24). Real-world data in the United Kingdom: Opportunities and challenges. BMC Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12916-016-0647-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free